$OMER

Omeros Corporation

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$2.05 -

Delayed Price

VOLUME

53,855

DAY RANGE

-

52 WEEK

1.86 - 8.33

Join Discuss about OMER with like-minded investors

profile
@maletone #StockTraders.NET
recently

$OMEr wants red

50 Replies 12 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

damn, $OMEr and $CFVI lower

73 Replies 9 👍 13 🔥

SO
@soheil.n #StockTraders.NET
recently

watchlist: main: $IMGN looking for 7.2-.4 reject $ABUS: will long if 4.8-5 holds...then looking for ss around 6 secondary: $OMER - push into previous supply zone $CFVI - no previous OH...may look for a long if it flushes or ss if it goes para

112 Replies 12 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

$OMEr to 7.80s seems feasible

44 Replies 9 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

will cover some $OMER under 8.50 but hoping we get some push

121 Replies 7 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

nice decent stuff on $OMEr wasnt able to add

96 Replies 11 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

omer webcast https://edge.media-server.com/mmc/p/m4mq9hpo

125 Replies 11 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

$OMER moving has a 49.4& IO so can skip and stuff

112 Replies 13 👍 11 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Monday, October 18, 2021 U.S. equity futures are looking lower after posting strong gains last week, with oil prices extending their near-term rally into a ninth consecutive week, as concerns over surging inflation pressures and the weakest China growth rate in more than a year tamed optimism linked to a strong start to the third quarter earnings season. Chinese Q3 GDP missed, rising +0.2% q/q vs 0.5% consensus, and was +4.9% y/y vs 5.2% consensus amid a rolling power crisis, supply chain disruptions and a crackdown on the tech sector. In the U.S., the earnings flood begins this week with 72 names in the S&P 500 expected to report quarterly results this week. In corporate news today, Apple (AAPL) is holding its second major launch event of the Fall where it is expected to unveil the first redesign of its MacBook Pro laptop in at least five years (starts at 1:00 PM ET). In Asian markets, The Nikkei Index dipped -43 points to 29,025, the Shanghai Index slipped a few points to settle at 3,568, and the Hang Seng Index rose 78 points to 25,409. In Europe, the German DAX is lower by -0.6% or nearly 100-points to drop below 15,500, while the FTSE 100 dips -0.3% to hold above the 7,200 level. U.S. stocks look to build on last week’s gains where large-cap tech names propelled the advance Friday, with shares of Amazon.com (AMZN) and Tesla (TSLA) each rising more than 3% on no specific news, while the SmallCap Russell 2000 underperformed, falling -0.35% as investors bailed on value stocks for growth stocks. Strong quarterly earnings from Dow component Goldman Sachs (GS) also boosted financials as investors prepare for a flood of reports next week. Shares of cryptocurrency and blockchain-related firms gained last week as bitcoin topped $60,000 for the first time since April, with expectations growing that U.S. regulators would allow a futures-based ETF. Market Closing Prices Yesterday The S&P 500 Index jumped 33.11 points, or 0.75%, to 4,471.37 The Dow Jones Industrial Average rose 382.20 points, or 1.09%, to 35,294.76 The Nasdaq Composite climbed 73.91 points, or 0.50%, to 14,897.34 The Russell 2000 Index declined -8.52 points, or 0.37% to 2,265.65 Events Calendar for Today 9:15 AM ET Industrial Production MoM for September…est. +0.2% 9:15 AM ET Capacity Utilization for September…est. 76.5% 10:00 AM ET NAHB Housing Market Index for October…est. 76 4:00 PM ET Net Long-term TIC Flows for August Earnings Calendar: Earnings Before the Open: ACI, GNTY, STT Earnings After the Close: CFB, ELS, FBK, FNB, HXL, PACW, SFBS, STLD, ZION Other Key Events: Apple (AAPL) announces October 18th event (New MacBooks, a Mac Mini, and AirPods are anticipated) Macro Up/Down Last Nymex 1.43 83.71 Brent 1.11 85.97 Gold -6.70 1,763.50 EUR/USD -0.0012 1.1586 JPY/USD 0.15 114.37 10-Year Note +0.042 1.618% World News China’s industrial output rose +3.1% in September from a year earlier, missing expectations of up +4.5%, and slowing from 5.3% in August, official data showed. Retail sales grew +4.4% in September on-year, compared with a forecast 3.3% increase and a 2.5% rise in August. Fixed asset investment increased +7.3% in the first nine months from the same period a year earlier, missing expectations for a +7.9% rise Chinese Q3 GDP missed, rising +0.2% q/q vs 0.5% consensus; +4.9% y/y vs 5.2% consensus; Chinese Q3 GDP YTD missed +9.8% y/y vs 10.1% consensus; Chinese Sep Unemployment Rate lower: 4.9% vs 5.1% consensus Sector News Breakdown Consumer Lennar ($LEN) said its board increased share repurchase authorization by up to the lesser of $1 billion in purchase price, or 25 million in shares, of the outstanding Class A or Class B common stock Zillow Group ($ZG) is taking a break from buying U.S. homes after the online real estate giant’s pivot into tech-powered house-flipping hit a snag, Bloomberg reported saying after buying more than 3,800 homes in Q2, it will stop pursuing new home purchases as it works through a backlog of properties already in its pipeline Energy, Industrials and Materials S. crude oil futures closed at fresh seven-year highs last week at $82.28 for WTI crude and $8.86 for Brent as a natural gas supply crunch in Europe and optimism about demand in the U.S. continued to propel the recent rally. For the week, WTI rose 3.7% and Brent added 3%, the eighth straight weekly gain for both. Occidental Petroleum ($OXY) upgraded to Buy from Hold at Truist Steel Dynamics ($STLD) downgraded to Equal Weight from Overweight at Morgan Stanley and firm also downgraded S. Steel (X) to Underweight from Equal Weight Virgin Galactic ($SPCE) downgraded to Sell from Neutral at UBS with $15 tgt Healthcare Biogen Inc’s ($BIIB) said a late-stage experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) failed to reach its main goal, but secondary measures and biomarkers showed favorable trends. Tofersen is designed to suppress the production of SOD1, a protein that can accumulate to toxic levels in ALS patients with mutations in a specific gene. Revance ($RVNC) shares fell over -30% late Friday after the FDA declined to approve its frown line injection treatment, citing issues with the company’s manufacturing facility; o other concerns were raised by the agency Avadel ($AVDL) shares slide over -20% after saying the U.S. FDA notified the co that the agency is still reviewing the marketing application of its sleep disorder drug, FT218, and the decision will likely not be taken this month (prior review was expected by Oct. 15) Omeros Corporation ($OMER) said they received a Complete Response Letter (CRL) from the U.S. FDA regarding its Biologics License Application ($BLA) for narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy ($HSCT-TMA). PTC Therapeutics ($PTCT) downgraded to Underperform from Neutral at Bank America with a $38 price target Oyster Point Pharma ($OYST) announced that the FDA has approved Tyrvaya Nasal Spray 0.03 mg for the treatment of the signs and symptoms of dry eye disease MeiraGTx ($MGTX) mentioned positively in Barron’s saying shares could more than double as the company will present its gene-regulating “switches” at next week’s conference of the European Society of Gene and Cell Therapy, and to Wall Street investors in mid-December. Notes shares have fallen from a 2019 peak of $30 to a recent $14, leaving its market cap below $600 million The plan to roll out Merck & Co’s ($MRK) promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution, potentially leaving the nations with the greatest need once again at the back of the line, international health groups say – Reuters Technology, Media & Telecom Dell Inc. ($DELL) with a positive mention in Barron’s saying the company is about to become much more attractive to investors as it prepares to spin off its valuable stake in software maker VMware (VMW) in early November, arguing that Dell will emerge with a solid balance sheet and simpler structure. Netflix ($NFLX) estimates that its latest megahit, “Squid Game,” will create almost $900 million in value for the company, and only cost about $21M to make. Netflix estimates that 89% of people who started the show watched at least 75 minutes – more than one episode – and 66% of viewers, or 87 million people, have finished the series in the first 23 days Disney ($DIS) downgraded to Equal Weight from Overweight at Barclays and cut tgt to $175 from $210 Members of a congressional committee questioned whether Amazon (AMZN) executives misled them during an investigation of the company’s business practices and if they may have lied under oath – WSJ reports Upstart ($UPST) downgraded to Underperform from Neutral at Bank America saying the LT thesis intact, but near-term upside priced in

80 Replies 9 👍 10 🔥

profile
@dros #droscrew
recently

Upgrades 10/8: $CCBG $HRL $LXP $NTRS $OTLY $PLUG $UNP . Downgrades 10/8: $ALLO $CABO $CAG $CHTR $CLLS $FAST $FHB $HD $JBHT $LOW $MDP $OMER $SIRI

141 Replies 13 👍 14 🔥

profile
@dros #droscrew
recently

Upgrades 10/4: $ALNY $BTU $DD $JBT $LUV $ROP $SJI $UNP . Downgrades 10/4: $AKAM $EQC $GWRE $IDA $IIVI $MMM $OMER $TSCO $VERX $WISH $XLRN

124 Replies 9 👍 15 🔥

profile
@DarkPoolAlgo #Dark Pool Charts
recently

Monday, August 9, 2021 Futures Up/Down % Last Dow -110.00 0.32% 34,979 S&P 500 -8.25 0.19% 4,421 Nasdaq 10.50 0.07% 15,106 Stock futures traded mostly lower Monday as investors increased bets the Federal Reserve would pull back on stimulus following a stronger-than-expected U.S. jobs report last week. Stocks closed higher on Friday, adding to its string of weekly advances as the S&P 500 index hits its 44th record high after a strong monthly jobs report fuels a further rotation into riskier assets. The U.S. economy added 943,000 jobs in July as hiring surged and employers raised wages to lure workers. It marked the second straight month of impressive growth. For the week, unofficially, the S&P rose 0.94%, the Dow added 0.78%, and the Nasdaq gained 1.11%. U.S. Treasury yields rose Friday after the jobs report, rising 8.7 bps at 1.3036%, its highest of the day, as equity indexes closed at record highs (back down at 1.28%). The financial sector saw its biggest daily percentage gain since July 20, while materials scored their best day in nearly a month as consumer discretionary stocks lagged. In Asian markets, The Nikkei Index gained 91 points to 27,820, the Shanghai Index rises 36 points (over 1%) to 3,494, the Hang Seng Index jumps 104 points to 26,283. In Europe, the German DAX is down -30 points to 15,730, while the FTSE 100 is down about -25 points, dipping just below 7,100. Bitcoin prices are higher by over 5% to $45,000 while Ethereum prices extend last week gains, also up over 5% topping $3,000. Oil prices looking lower again as WTI Crude slips 3.75% or over $2.50 to $65.70 (lowest levels since June) as worries about the COVID Delta variant’s impact on global growth increase. Goldman Sachs cut its forecast for China Q3 and full-year GDP, but does expect the government to bring the outbreak under control in about a month. Also, China’s crude imports slipped to the lowest since May last month after operations were halted at key ports on the east coast due to a typhoon. The nation imported 41.24 metric tons of crude in July, according to data. Gold prices slide $22 or over 1$ at $1,742.00 an ounce – but well-off overnight lows after plunging just below $1,700 an ounce Market Closing Prices Yesterday The S&P 500 Index gained 7.42 points, or 0.17%, to 4,436.52 The Dow Jones Industrial Average rose 144.26 points, or 0.41%, to 35,208.51 The Nasdaq Composite declined -59.36 points, or 0.40%, to 14,835.76 The Russell 2000 Index advanced 11.75 points, or 0.53% to 2,247.76 Events Calendar for Today 10:00 AM EST JOLTs Job Openings for June Earnings Calendar: Earnings Before the Open: AGEN, AMRX, APD, AVYA, AXSM, BALY, BFLY, BHV, CEVA, CRNC, DISH, DRNA, DS, EBIX, ELAN, ENR, EPZM, HE, III, ITCI, JOUT, KOS, LINC, MPAA, RDNT, SCPL, SGMS, SNDX, TGNA, TSN, TTD, USFD, VTRS, WHF, WKHS Earnings After the Close: ACM, ADMS, AMC, APEI, APPF, APPS, ASUR, AVD, BCEI, BRP, CABO, CARA, CBT, CCXI, CF, CMBM, CMP, CSTL, CXW, DDD, DOOR, ELY, ETH, EVBG, FGEN, FSK, FTK, GBDC, GOOD, HALO, IIIV, IIN, INO, IPAR, LOTZ, MESA, MODN, MYO, NCMI, NHI, OMER, OSH, OUST, PEN, PLNT, PRPL, QLYS, REAL, REI, RETA, RPAY, SAIL, SENS, SNCR, STE, SWAV, TALK, TPTX, VUZI, WES, ZIOP Other Key Events: BTIG Biotechnology Conference 2021 (virtual), 8/9-8/10 Cowen Annual Communications Infrastructure Hybrid Summit, 8/9-8/12 Cowen 9th Annual Internet & Media Bus Tour (virtual), 8/9-8/13 KeyBanc Capital Markets Technology Leadership Virtual Forum, 8/9-8/12 Needham 10th Annual Industrial Technologies 1:1 Conference (virtual), 8/6-8/9 Macro Up/Down Last Nymex -2.60 65.68 Brent -2.53 68.17 Gold -22.00 1,741.00 EUR/USD -0.0006 1.1756 JPY/USD -0.08 110.17 10-Year Note -0.008 1.28% World News China’s export growth slowed in July, adding to concerns the economy’s recovery will face fresh pressure in the second half of the year. Exports grew 19.3% in dollar terms in July from a year earlier, while imports rose 28.1%, the customs administration said Saturday. That left a trade surplus of $56.58 billion for the month. Sector News Breakdown Consumer Sanderson Farms ($SAFM) is said close to a deal to sell itself to Cargill and Continental Grain for about $4.5B. The deal, which could be announced as soon as tomorrow, is expected to value Sanderson Farms (SAFM) at $203 per share – WSJ https://on.wsj.com/3yAS4dD Philip Morris ($PM) has raised its bid for British drugmaker Vectura ($VEGPF) to 165 pence, or $2.29, per share, according to Reuters, citing the tobacco company. Tesla ($TSLA) upgraded to Buy from Hold at Jefferies and up tgt to $850 from $700 as sees higher global battery electric demand, more battery and assembly capacity coming on stream, a broader and mix-accretive model line-up with more Model Ys and the new S and no legacy issues to contend with Conagra Brands ($CAG) files automatic mixed securities shelf Spectrum Brands Holdings ($SPB) mentioned positively in Barron’s, calling it an undervalued stock that lets investors bet on multiple Covid-era trends at once. It has the defensive characteristics of a consumer- staples brand and its debt problems appear to be easing. Ross Stores ($ROST) and WW Int’l ($WW) will benefit from shoppers buying new wardrobes and getting back in shape for a return to the office according to Barron’s. Starbucks ($SBUX) and Ruth’s Hospitality Group ($RUTH) fell on delta concerns, but both have seen sales momentum as cities reopen ManpowerGroup ($MAN) announces new stock repurchase program for up to 4M shares Haverty’s ($HVT) announces new $25M stock repurchase program Energy Oil prices looking lower as WTI Crude slips 3.75% or over $2.50 to $65.70 (lowest levels since June) as worries about the COVID Delta variant’s impact on global growth increase. Goldman Sachs cut its forecast for China Q3 and full-year GDP, but does expect the government to bring the outbreak under control in about a month. Also, China’s crude imports slipped to the lowest since May last month after operations were halted at key ports on the east coast due to a typhoon. The nation imported 41.24 metric tons of crude in July, according to data. Saudi Aramco made net profit of 95.5 billion riyals ($25.5 billion) in the second quarter, the highest level since the end of 2018. Free cash flow rose to $22.6 billion Financials Berk­shire Hath­away Inc. ($BRKA) said Q2 net earn­ings rose 7%, boosted by im­proved re­sults for its rail­road, util­i­ties and en­ergy com­pa­nies. Op­er­at­ing earn­ings, which ex­clude some in­vest­ment re­sults, rose to $6.7B from $5.5B in the year prior. Prof­its in­creased within the com­pa­ny’s rail-road, util­i­ties and en­ergy di­vi­sions but de­clined at the com­pa­ny’s vast in­sur­ance op­er­a­tions Hudson Pacific Properties ($HPP), a real estate investment trust that leases space in West Los Angeles, could gain on bets its Hollywood producer and plastic surgeon tenants won’t give up their offices according to Barron’s. Boston Properties ($BXP) was also recommended for its exposure to the thriving health care and tech sectors in Boston and the San Francisco Bay Area. DiamondRock ($DRH) files automatic mixed securities shelf Healthcare Exact Sciences ($EXAS) has approached Invitae ($NVTA) about a possible merger, Bloomberg reported late Friday while saying the companies are not in active talks, and if a deal materializes, it could be an all-stock deal with a low premium https://bit.ly/37wMxch Eton Pharmaceuticals’ ($ETON) antiepileptic topiramate oral solution FDA action date has been delayed three months to November 6, 2021, according to an SEC filing after a decision was expected on Friday. Lexicon ($LXRX) files $200M mixed securities shelf Epizyme Inc. ($EPZM) rises after announcing a deal with Hutchmed China to develop Tazverik, a medicine used to treat certain patients with epithelioid sarcoma and others with follicular lymphoma Elanco ($ELAN) Q2 adj EPS $0.28 vs. rest. $0.26; Q2 revs $1.28B vs. est. $1.23B; sees Q3 adj EPS $0.15-$0.19 vs. est. $0.20; sees Q3 revs $1.075B-$1.1B vs. est. $1.09B Industrials & Materials HVAC stocks Carrier Global ($CARR), Lennox International ($LII), Trane Technologies ($TT), and Johnson Controls International ($JCI)-have all reported strong calendar Q2 earnings and are up an average of more than 40% this year, according to Barron’s. Article notes the HVAC business is rapidly becoming one of the most consistent end markets in the industrial universe, and it’s also becoming an important ESG play Air Products ($APD) Q3 adj EPS $2.31 vs. est. $2.36; Q3 revs $2.6B vs. est. $2.49B; sees Q4 adj EPS $2.44-$2.54 vs. est. $2.51; narrows FY21 adj EPS view to $8.95-$9.05 from $8.95-$9.10 (est. $9.07); sees 2021 cap-ex spending of about $2.5B Barrick Gold ($GOLD) Q2 adj EPS $0.29 vs. est. $0.28; Q2 revs $2.89B vs. est. $3.06B Technology, Media & Telecom Dish ($DISH) Q2 EPS $1.06 vs. est. $0.89; Q2 revs $4.49B vs. est. $4.43B; Q2 Net Pay-TV subscribers decreased approximately 67,000, compared to a net decrease of approximately 96,000 in the year-ago quarter; closed the quarter with 10.99M Pay-TV subscribers, including 8.55M DISH TV subscribers and 2.44M SLING TV subscribers Nokia ($NOK) could continue to rally (after rising 56% YTD) according to Barron’s as it recovers from a period of underperformance. It will benefit from telecom operators upgrading their equipment to support 5G and the work- at-home trend. It’s also a meme stock favored by retail investors. Corporate tech spending is forecast to rise again, and two stocks to benefit from the trend are Microsoft ($MSFT) and Cisco Systems ($CSCO), according to Barron’s. LinkedIn, owned by Microsoft, could get a boost from increased worker mobility and job listings. Evercore ISI analyst Amit Daryanani sees a path for Cisco to reach $100 per share TikTok owner ByteDance Ltd. is reviving plans to list in Hong Kong by early next year even as Chinese authorities widen their crackdown on the country’s technology companies, the Financial Times reported

94 Replies 15 👍 7 🔥

profile
@thegiz18 #ivtrades
recently

Earnings after close today include $DDD, $CLOV, $INO, $LMND, $NIO, $OMER, $NVAX, SRPT, $ZM

96 Replies 15 👍 6 🔥

AL
@Aliamer #ivtrades
recently

I saw sweep in OMER Feb 10000 contacts for 4.6 then one more 10000 in Aug

52 Replies 6 👍 15 🔥

profile
@MT #StockTraders.NET
recently

watchlist: $LIZI $OMER $ESTC $JAZZ $COGT $CEMI $HDSN

112 Replies 14 👍 11 🔥

profile
@MT #StockTraders.NET
recently

$OMER billing status approved for Omidria

45 Replies 11 👍 9 🔥

profile
@thegiz18 #ivtrades
recently

Good morning, futures are rather flat this morning, US dollar still showing weakness at 2.5 yr lows, with $DXY dipping below 91 overnight. Gold and silver are modestly higher, crude under pressure with OPEC+ still arguing over extending production cuts or whether to begin increasing output. Decision could come today or be pushed back again. $LGVW looks to have found support after daily pullback and could be ready to tackle highs again. $CRWD good earnings results, $OMER with a big after market jump not sure of the news. $SPLK down big on earnings results. $BA holding yesterdays move and adding a bit more premarket. Trade your plan and trade well.

146 Replies 12 👍 11 🔥

profile
@dros #droscrew
recently

largest call/put $OMER

55 Replies 8 👍 9 🔥

profile
@thegiz18 #ivtrades
recently

$OMER right back down under $15 after spiking to over $25 Monday, priced secondary stock offering at $14.50

59 Replies 9 👍 8 🔥

profile
@steve66 #ivtrades
recently

UOA Omer proposed a stock offering sank on news overnight but hasn’t offered as yet never know with biotech when they will do that

126 Replies 7 👍 14 🔥

profile
@RedSunCap #droscrew
recently

4853 $OMER Dec20 25.0 Calls trade $3.75

91 Replies 12 👍 15 🔥

profile
@RedSunCap #droscrew
recently

4853 $OMER Dec20 25.0 Calls trade $3.75

120 Replies 8 👍 12 🔥

profile
@ivtrades-Chris #ivtrades
recently

4853 $OMER Dec20 25.0 Calls trade $3.75 (FT Theo=3.15) ASKSIDE [ARCA] 10:24:05 IV=119.1% +21.5 FLOOR - OPENING Post-Earnings / SSR Vol=5011, OI=85,

46 Replies 8 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

$OMER offering

91 Replies 7 👍 15 🔥

profile
@dros #droscrew
recently

damn look at this $OMER move today

45 Replies 12 👍 6 🔥

profile
@rickhaus #StockTraders.NET
recently

watching $OMER to short

46 Replies 14 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

OMER might run wild too

93 Replies 11 👍 12 🔥

profile
@thegiz18 #ivtrades
recently

Little $OMER woke up on drug news

95 Replies 11 👍 7 🔥

Key Metrics

Market Cap

128.60 M

Beta

1.69

Avg. Volume

554.42 K

Shares Outstanding

62.73 M

Yield

0%

Public Float

0

Next Earnings Date

2023-02-28

Next Dividend Date

Company Information

Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system and immune-related diseases, including cancers. Its commercial product OMIDRIA® (phenylephrine and ketorolac intraocular solution) 1%/0.3% continues to gain market share in cataract surgery. Omeros' lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject of a biologics license application under priority review by FDA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Narsoplimab is also in multiple late-stage clinical development programs focused on other complement-mediated disorders, including IgA nephropathy, atypical hemolytic uremic syndrome and COVID-19. OMS906, Omeros' inhibitor of MASP-3, the key activator of the alternative pathway of complement, is in a Phase 1 clinical trial, and the company's PDE7 inhibitor program OMS527, targeting addiction and movement disorders, has successfully completed a Phase 1 trial. Omeros' pipeline holds a diverse group of preclinical programs including a proprietary-asset-enabled antibody-generating technology and a proprietary GPCR platform through which it controls 54 GPCR drug targets and their corresponding compounds. One of these novel targets, GPR174, modulates a new cancer immunity axis recently discovered by Omeros, and the company is advancing GPR174-targeting antibodies and small-molecule inhibitors.

CEO: Gregory Demopulos

Website:

HQ: 201 Elliott Ave W Seattle, 98119-4240 Washington

Related News